Ausgabe 2/2013
Inhalt (27 Artikel)
The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy
Mun Hui, Aurélie Cazet, Radhika Nair, D Neil Watkins, Sandra A O'Toole, Alexander Swarbrick
Closing escape routes: inhibition of IL-8 signaling enhances the anti-tumor efficacy of PI3K inhibitors
Ashish Juvekar, Gerburg M Wulf
DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer
Xuedong Yin, Tingxiu Xiang, LiLi Li, Xianwei Su, Xingsheng Shu, Xinrong Luo, Jianbo Huang, Ying Yuan, Weiyan Peng, Michael Oberst, Kathleen Kelly, Guosheng Ren, Qian Tao
Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer
Marc-André Déry, Julie Jodoin, Josie Ursini-Siegel, Olga Aleynikova, Cristiano Ferrario, Saima Hassan, Mark Basik, Andréa C LeBlanc
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
John FR Robertson, J Michael Dixon, D Mark Sibbering, Ali Jahan, Ian O Ellis, Eddie Channon, Pauline Hyman-Taylor, Robert I Nicholson, Julia MW Gee
Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II
Renée T Fortner, A Heather Eliassen, Donna Spiegelman, Walter C Willett, Robert L Barbieri, Susan E Hankinson
Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer
Areti Strati, Sabine Kasimir-Bauer, Athina Markou, Cleo Parisi, Evi S Lianidou
HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
Laurel A Habel, Lori C Sakoda, Ninah Achacoso, Xiao-Jun Ma, Mark G Erlander, Dennis C Sgroi, Louis Fehrenbacher, Deborah Greenberg, Charles P Quesenberry Jr
Embryonic mammary signature subsets are activated in Brca1 -/- and basal-like breast cancers
Marketa Zvelebil, Erik Oliemuller, Qiong Gao, Olivia Wansbury, Alan Mackay, Howard Kendrick, Matthew J Smalley, Jorge S Reis-Filho, Beatrice A Howard
Risk of breast cancer in Lynch syndrome: a systematic review
Aung Ko Win, Noralane M Lindor, Mark A Jenkins
Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer
Benjamin A Katchman, I Tolgay Ocal, Heather E Cunliffe, Yu-Hui Chang, Galen Hostetter, Aprill Watanabe, Janine LoBello, Douglas F Lake
The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker
Michael L Salmans, Fang Zhao, Bogi Andersen
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
Hannah Harrison, Bruno M Simões, Lynsey Rogerson, Sacha J Howell, Göran Landberg, Robert B Clarke
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
Rita D Brandão, Jürgen Veeck, Koen K Van de Vijver, Patrick Lindsey, Bart de Vries, Catharina HMJ van Elssen, Marinus J Blok, Kristien Keymeulen, Torik Ayoubi, Hubert JM Smeets, Vivianne C Tjan-Heijnen, Pierre S Hupperets
Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experience
Paul M Meaney, Peter A Kaufman, Lori S Muffly, Michael Click, Stephen P Poplack, Wendy A Wells, Gary N Schwartz, Roberta M di Florio-Alexander, Tor D Tosteson, Zhongze Li, Shireen D Geimer, Margaret W Fanning, Tian Zhou, Neil R Epstein, Keith D Paulsen
Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium
Fabienne Meier-Abt, Emanuela Milani, Tim Roloff, Heike Brinkhaus, Stephan Duss, Dominique S Meyer, Ina Klebba, Piotr J Balwierz, Erik van Nimwegen, Mohamed Bentires-Alj
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma
Nirukshi U Samarajeewa, Fangyuan Yang, Maria M Docanto, Minako Sakurai, Keely M McNamara, Hironobu Sasano, Stephen B Fox, Evan R Simpson, Kristy A Brown
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
Alison F Munro, Annette Bartels, Eva Balslev, Christopher J Twelves, David A Cameron, Nils Brünner, John MS Bartlett
Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling
Lopamudra Das Roy, Jennifer M Curry, Mahnaz Sahraei, Dahlia M Besmer, Amritha Kidiyoor, Helen E Gruber, Pinku Mukherjee
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs
Muhammad Riaz, Marijn TM van Jaarsveld, Antoinette Hollestelle, Wendy JC Prager-van der Smissen, Anouk AJ Heine, Antonius WM Boersma, Jingjing Liu, Jean Helmijr, Bahar Ozturk, Marcel Smid, Erik A Wiemer, John A Foekens, John WM Martens
Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer
Sepideh Gholami, Chun-Hao Chen, Laurence J Belin, Emil Lou, Sho Fujisawa, Caroline Antonacci, Amanda Carew, Nanhai G Chen, Marina De Brot, Pat B Zanzonico, Aladar A Szalay, Yuman Fong
Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis
Sahra Borges, Heike Döppler, Edith A Perez, Cathy A Andorfer, Zhifu Sun, Panos Z Anastasiadis, E Aubrey Thompson, Xochiquetzal J Geiger, Peter Storz
Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study
Roni T Falk, Louise A Brinton, Joanne F Dorgan, Barbara J Fuhrman, Timothy D Veenstra, Xia Xu, Gretchen L Gierach